CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Groupe Francophone des Myelodysplasies

Academic/HospitalWebsite ↗

Also known as: Groupe Francophone des MyÃ©lodysplasies | Groupe francophone des Myelodisplasies | Groupe Francophone des Myelodysplasies

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2025

Timeline

2000s

Jan 1, 2003
Groupe Francophone des Myelodysplasies— Founded

Drugs by trial phase (40 distinct, 44 trials)

Phase 3 (10 own, 0 via acquisition)

Phase 2 (29 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

sonidegib

Indications

Studied for

Recent trials (50)

NCT07098936Lead sponsorPhase 2Oct 31, 2025
NCT06670222Lead sponsorPhase 1Feb 28, 2025
NCT05782127Lead sponsorPhase 1/Phase 2Nov 30, 2023
NCT05768711Lead sponsorPhase 2Oct 4, 2023
NCT05583552CollaboratorPhase 2Dec 31, 2022
NCT05226455Lead sponsorPhase 1/Phase 2Sep 1, 2022
NCT05181735Lead sponsorPhase 1/Phase 2May 18, 2022
NCT04857645Lead sponsorPhase 2Jun 22, 2021
NCT04827719Lead sponsorPhase 2May 1, 2021
NCT04273802Lead sponsorPhase 1/Phase 2Mar 15, 2020
NCT03744390Lead sponsorPhase 2Feb 12, 2019
NCT03824080CollaboratorPhase 2Dec 20, 2018
NCT03454984Lead sponsorPhase 2Sep 30, 2018
NCT03588078Lead sponsorPhase 1/Phase 2Sep 15, 2018
NCT03503409Lead sponsorPhase 2Aug 1, 2018

Details

Founded: Paris, FR Jan 1, 2003
Last known activity: Oct 31, 2025